Assisted Reproductive Technologies
- 2 Downloads
Since the first successful in vitro fertilization pregnancy (IVF), the progress of assisted reproduction has been surprising. With developments such as intracytoplasmic sperm injection (ICSI), egg and sperm donation, preimplantation diagnosis, and aneuploidy screening, there are many more couples who can benefit from assisted reproductive technologies (ART).
Endocrine dysfunctions represent the indication for treatments in 5–19.8%, and probably these figures are underestimated. The evaluation and treatment of women with poor ovarian reserve and polycystic ovarian (PCO) syndrome in ART remain a challenge. Numerous protocols and procedures have been proposed, but none has yet reached sufficient evidence.
In this chapter, the most used techniques of assisted reproduction and newer developments are discussed, as well as the possible complications associated with ART. Furthermore, the strategies employed during the procedure in patients with reduced ovarian reserve and PCO have been deepened.
KeywordsAssisted reproductive technologies IVF ICSI Poor responder PCO
- Bartal MF, Sibai BM, Bart Y, Shina A, Mazaki-Tovi S, Eisen IS, et al. The impact of sperm and egg donation on the risk of pregnancy complications. Am J Perinatol. 2018;47:41.Google Scholar
- Berger JJ, Bates GW. Optimal management of subfertility in polycystic ovary syndrome. Int J Women’s Health. 2014;6:613–21.Google Scholar
- Boomsma CM, Heineman MJ, Cohlen BJ, Farquhar C. Semen preparation techniques for intrauterine insemination. Cochrane Database Syst Rev. 2007;(4). Art. No.: CD004507.Strandell et al. 2003.Google Scholar
- Chen ZJ, Shi Y, Sun Y, Zhang B, Liang X, Cao Y, Yang J, Liu J, Wei D, Weng N, Tian L, Hao C, Yang D, Zhou F, Shi J, Xu Y, Li J, Yan J, Qin Y, Zhao H, Zhang H, Legro RS. Fresh versus Frozen Embryos for Infertility in the Polycystic Ovary Syndrome N Engl J Med. 2016, 11;375(6):523–33.PubMedCrossRefPubMedCentralGoogle Scholar
- Davar R, Neghab N, Naghshineh E. Pregnancy outcome in delayed start antagonist versus microdose flare GnRH agonist protocol in poor responders undergoing IVF/ICSI: an RCT. Int J Reprod Biomed (Yazd). 2018;16(4):255–60.Google Scholar
- De Geyter C, Calhaz-Jorge C, Kupka MS, Wyns C, Mocanu E, Motrenko T et al. European IVF-monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE). ART in Europe, 2014: results generated from European registries by ESHRE: the European IVF-monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE). Hum Reprod. 2018.Google Scholar
- ESHRE fact sheets 3 January 2017.Google Scholar
- ESHRE fact sheet, Updated 18 February 2018.Google Scholar
- Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L, on behalf of the ESHRE working group on Poor Ovarian Response Definition. ESHRE consensus on the definition of “poor response” to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26:1616–24.PubMedCrossRefPubMedCentralGoogle Scholar
- Good Clinical Treatment in Assisted Reproduction – An ESHRE position paper. June 2008.Google Scholar
- Hou H, Wang X, Yu Q, Li HY, Li SJ, Tang RY, Guo ZX, Chen YQ, Hu CX, Yang ZJ, Zhang WK, Qin Y. Evidence that growth hormone can improve mitochondrial function in oocytes from aged mice. Reproduction. 2019. REP-18-0529.R1.Google Scholar
- NICE Last updated: September 2017 – National Institute for Health and Care Excellence. Fertility problems: assessment and treatment.Google Scholar
- Reichman DE, Gunnala V, Meyer L, Spandorfer S, Schattman G, Davis OK, et al. In vitro fertilization versus conversion to intrauterine insemination in the setting of three or fewer follicles: how should patients proceed when follicular response falls short of expectation? Fertil Steril. 2013;100(1):94–9.PubMedCrossRefPubMedCentralGoogle Scholar
- Vaiarelli A, et al. What is new in the management of poor ovarian response in IVF? CurrOpinObstet Gynecol. 2018;30(3):155–62.Google Scholar
- van Tilborg TC, Torrance HL, Oudshoorn SC, Eijkemans MJC, Koks CAM, Verhoeve HR, et al. OPTIMIST study group. Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 1: the predicted poor responder. Hum Reprod. 2017;32(12):2496–505.PubMedCrossRefPubMedCentralGoogle Scholar
- von Wolff M, Kollmann Z, Fluck CE, Stute P, Marti U, Weiss B, et al. Gonadotrophin stimulation for in vitro fertilization significantly alters the hormone milieu in follicular fluid: a comparative study between natural cycle IVF and conventional IVF. Hum Reprod. 2014;29:1049–57.CrossRefGoogle Scholar